ELMSFORD, N.Y. & MINNEAPOLIS--(BUSINESS WIRE)--May 3, 2005--BioScrip, Inc. (NASDAQ:BIOS), today reported revenue of $188.4 million and diluted earnings per share of $0.06 for the first quarter ended March 31, 2005. The reported results include financial results of MIM Corporation for the full quarter and financial results of Chronimed Inc. from March 13 through March 31, 2005. The financial results also include merger and related expenses and associated amortization expense of $0.6 million ($0.4 million net of taxes) related to the company’s merger with Chronimed Inc. Excluding these expenses, diluted earnings per share for the quarter would have been $0.08. As previously reported, MIM Corporation completed its merger with Chronimed Inc. effective March 12, 2005, changing its name to BioScrip, Inc.
